Domů › Rakovina prostaty › Maryland › Baltimore
Klinické studie Rakovina prostaty v Baltimore, MD
43 studií pro Rakovina prostaty hledá účastníky v lokalitách v Baltimore a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Probíhá náborFáze 3
- Maryland Proton Treatment Center, Baltimore
- University of Maryland/Greenebaum Cancer Center, Baltimore
- UM Baltimore Washington Medical Center/Tate Cancer Center, Glen Burnie · Vzdálenost 9 mi
- a dalších 1
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- a dalších 2
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 2
- Johns Hopkins University, Baltimore
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
Probíhá náborObservační studie
- Chesapeake Urology Associates, Towson · Vzdálenost 8 mi
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
Probíhá náborFáze 1
- University of Maryland, Greenebaum Comprehensive Cancer Center, Baltimore
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Probíhá náborFáze 3
- Baltimore Veterans Affairs Medical Center ( Site 0069), Baltimore
- Greenebaum Comprehensive Cancer Center ( Site 0049), Baltimore
- Chesapeake Urology ( Site 0009), Towson · Vzdálenost 8 mi
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Probíhá náborFáze 3
- University of Maryland Greenebaum Cancer Center, Baltimore
- Johns Hopkins Hospital Sidney Kimmell Comprehensive Cancer Center, Baltimore
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Probíhá náborFáze 3
- Research Site, Towson · Vzdálenost 8 mi
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Probíhá náborFáze 3
- Greenebaum Comprehensive Cancer Center ( Site 0021), Baltimore
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
Probíhá náborObservační studie
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Probíhá náborFáze 2
- Chesapeake Urology Research Associates, Towson · Vzdálenost 8 mi
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Probíhá nábor
- Anne Arundel Urology, Annapolis · Vzdálenost 22 mi
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Probíhá náborFáze 3
- Maryland Proton Treatment Center, Baltimore
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Veterans Administration Medical Center-Baltimore, Baltimore
- a dalších 4
Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
Probíhá nábor
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Transrectal Ultrasound Robot-Assisted Prostate Biopsy
Probíhá nábor
- Johns Hopkins Hospital, Baltimore
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
Probíhá náborFáze 2
- University of Maryland Greenebaum Cancer Center, Baltimore
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Probíhá náborFáze 1/2
- Johns Hopkins Hospital, Baltimore
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Probíhá náborFáze 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1/2
- Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Probíhá náborFáze 1
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
Probíhá náborObservační studie
- Johns Hopkins University, Baltimore
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Probíhá náborFáze 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
Probíhá náborFáze 2
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Probíhá náborFáze 1
- Marlene & Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore
7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer
Probíhá nábor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
The COSMYC Trial (COmbined Suppression of MYC)
Probíhá náborFáze 2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Probíhá náborFáze 1
- Advanced Molecular Imaging and Therapy, Glen Burnie · Vzdálenost 9 mi
- United Theranostics - Chesapeake, Glen Burnie · Vzdálenost 9 mi
TERPS Trial for de Novo Oligometastic Prostate Cancer
Probíhá náborFáze 2
- Maryland Proton Treatment Center, Baltimore
- UMMC, Baltimore
- Baltimore Washington Medical Center, Glen Burnie · Vzdálenost 9 mi
- a dalších 1
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Probíhá náborObservační studie
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Clinical Trial of Approaches to Prostate Cancer Surgery
Probíhá nábor
- Johns Hopkins University, Baltimore
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Probíhá náborFáze 2/3
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization
Probíhá náborObservační studie
- Johns Hopkins University, Baltimore
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
Probíhá náborFáze 2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer
Probíhá náborFáze 2
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
Probíhá náborRaná fáze 1
- SKCCC at Johns Hopkins, Baltimore
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Probíhá náborFáze 1
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Probíhá náborFáze 1
- Chesapeake Urology, Towson · Vzdálenost 8 mi
Physician- and Patient-based Barriers to NGS Testing
Probíhá nábor
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
Probíhá náborFáze 2
- Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe
Probíhá náborFáze 1
- Johns Hopkins Hospital, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · Vzdálenost 8 mi
Exercise in Prostate Cancer
Probíhá nábor
- Johns Hopkins University, Baltimore
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Probíhá náborFáze 1/2
- Johns Hopkins, Baltimore
Studie Rakovina prostaty v jiných městech
- New York City, NY103 studií
- Houston, TX76 studií
- Los Angeles, CA61 studií
- Boston, MA59 studií
- St. Louis, MO46 studií
- Chicago, IL45 studií
- San Francisco, CA45 studií
- Philadelphia, PA44 studií
- Nashville, TN42 studií
- Seattle, WA42 studií
- Washington, DC38 studií
- Dallas, TX36 studií
Další studie v Baltimore
- Nemalobuněčný plicní karcinom60 studií
- Rakovina prsu47 studií
- Rakovina plic40 studií
- Rakovina (všechny typy)37 studií
- Kolorektální karcinom31 studií
- Rakovina slinivky břišní31 studií
- Metastatický karcinom28 studií
- Obesity25 studií
- Srdeční selhání24 studií
- Rakovina močového měchýře24 studií
- Mrtvice22 studií
- Rakovina vaječníků22 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.